Showing results (1101-1110 of 2,450) with videos related to

Sort By:
Pageof 245
International Journal of Pharmaceutics|August 3, 2007
Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stabilityK Morand, A C Bartoletti, A Bochot, et al.
Pediatric Nephrology (Berlin, Germany)|October 1, 1994
Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiencyS E Ledermann, A Johnson, M J Dillon, et al.
Archives of Disease in Childhood|July 1, 1987
Five year prospective study of plasma renin activity and blood pressure in patients with longstanding reflux nephropathyJ M Savage, C T Koh, V Shah, et al.
Basic & Clinical Pharmacology & Toxicology|April 1, 2018
CYP3A5*3 and ABCB1 61A>G Significantly Influence Dose-adjusted Trough Blood Tacrolimus Concentrations in the First Three Months Post-Kidney TransplantationRong Hu, Daniel T Barratt, Janet K Coller, et al.
Science (New York, N.Y.)|June 25, 2016
Childhood undernutrition, the gut microbiota, and microbiota-directed therapeuticsLaura V Blanton, Michael J Barratt, Mark R Charbonneau, et al.
Archives of Disease in Childhood|July 1, 1989
Early markers of the renal complications of insulin dependent diabetes mellitusD M Gibb, D Dunger, M Levin, et al.
Circulation. Cardiovascular Genetics|June 16, 2017
Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic CardiomyopathySamantha Barratt Ross, Richard D Bagnall, Jodie Ingles, et al.
Blood Pressure|April 28, 2018
Familial aggregation of first degree relatives of children with essential hypertensionMonesha Gupta-Malhotra, Syed Shahrukh Hashmi, Michelle S Barratt, et al.
Patient Education and Counseling|February 13, 2010
Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old womenErin Mathieu, Alexandra L Barratt, Kevin McGeechan, et al.
Journal of Leukocyte Biology|September 2, 2016
Dual inhibition of complement and Toll-like receptors as a novel approach to treat inflammatory diseases-C3 or C5 emerge together with CD14 as promising targetsAndreas Barratt-Due, Søren Erik Pischke, Per H Nilsson, et al.
Pageof 245